Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Vaccination Programme

Dáil Éireann Debate, Thursday - 15 July 2021

Thursday, 15 July 2021

Ceisteanna (379, 395, 418, 452)

Michael Ring

Ceist:

379. Deputy Michael Ring asked the Minister for Health when persons aged between 60-69 can expect to receive their second dose of a vaccine (details supplied); and if he will make a statement on the matter. [32520/21]

Amharc ar fhreagra

Alan Kelly

Ceist:

395. Deputy Alan Kelly asked the Minister for Health if an alternative MRNA vaccine will be made available for those in the 50-69 age cohort if a vaccine (details supplied) is not available within an eight week period for the second dose of the vaccine; and if he will make a statement on the matter. [32796/21]

Amharc ar fhreagra

Martin Kenny

Ceist:

418. Deputy Martin Kenny asked the Minister for Health the position for persons aged over 60 receiving the second dose of a vaccine (details supplied); if the time between vaccines will be reduced from 12 weeks; and if he will make a statement on the matter. [32854/21]

Amharc ar fhreagra

Brendan Griffin

Ceist:

452. Deputy Brendan Griffin asked the Minister for Health if he will address a matter regarding Covid-19 vaccinations (details supplied); and if he will make a statement on the matter. [33136/21]

Amharc ar fhreagra

Freagraí scríofa

I propose to take Questions Nos. 379, 395, 418 and 452 together.

On 4 June I announced a shorter interval between doses for the Vaxzevria® (AstraZeneca) vaccine. This follows updated recommendations from the National Immunisation Advisory Committee (NIAC), which have been endorsed by the Chief Medical Officer. NIAC has concluded that those of any age (without any previous COVID-19 infection), who have received their first dose of Vaxzevria® should receive their second dose 8-12 weeks later.The HSE recently received updated advice from NIAC in relation to reducing the dosing interval for the administration of the AstraZeneca vaccine from 12 weeks to 8. Extensive planning has been required to put in place a programme that will now see the remaining, approximately 450,000 people, in receipt of the AstraZeneca vaccine fully immunised through the administration of this second dose and it is expected to be substantially completed by 19 July.

Barr
Roinn